rotation.to
Following this device: dark.
Free account
rotation.to
Sign in / Request free access
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

Who

5AM Ventures VI, L.P.

10% owner

Company insider

Files Form 4 as: 10% owner, Latigo Biotherapeutics; 10% owner, Enliven Therapeutics.

Every Form 4 they filed

In numbers

Trades disclosed
8
Buys
0
Sells
1
Bought
$0
Sold
$12.3M
Companies
2
Companies where not an officer
2
First trade
14 Feb 2024
Last trade
10 Aug 2026
Last filed
12 Aug 2026

Companies traded

Everywhere else they filed: board seats, 10% stakes, other companies
LTGO Latigo Biotherapeutics10% owner · Biotechnology · last 10 Aug 20260 buys · 0 sells
ELVN Enliven Therapeutics10% owner · Biotechnology · last 14 Feb 20240 buys · 1 sell

Activity over time

1 Nov 2024 – 1 Oct 2026
101Nov 24May 25Nov 25Apr 26Oct 26

Buys above the line, sells below, each month.

Every trade

TradedCompanyWhatAmount
10 Aug 2026filed 12 Aug 2026LTGO Latigo BiotherapeuticsBiotechnologySEC FORM 4 Code C—4,975,543filing
10 Aug 2026filed 12 Aug 2026LTGO Latigo BiotherapeuticsBiotechnologySEC FORM 4 Code C—2,350,419filing
10 Aug 2026filed 12 Aug 2026LTGO Latigo Biotherapeuticsoption or derivative · BiotechnologySEC FORM 4 Code C—3,152,305 at $0.00filing
10 Aug 2026filed 12 Aug 2026LTGO Latigo Biotherapeuticsoption or derivative · BiotechnologySEC FORM 4 Code C—1,823,238 at $0.00filing
10 Aug 2026filed 12 Aug 2026LTGO Latigo Biotherapeuticsoption or derivative · BiotechnologySEC FORM 4 Code C—866,018 at $0.00filing
10 Aug 2026filed 12 Aug 2026LTGO Latigo Biotherapeuticsoption or derivative · BiotechnologySEC FORM 4 Code C—1,484,401 at $0.00filing
14 Feb 2024filed 16 Feb 2024ELVN Enliven TherapeuticsBiotechnologySEC FORM 4 Sold$10.3M688,358 at $14.90filing
14 Feb 2024filed 16 Feb 2024ELVN Enliven TherapeuticsBiotechnologySEC FORM 4 Sold$2.0M136,642 at $14.90filing

Sectors

Health Care1

Buys in green, sells in red, by the company’s sector.

Related people

5AM Partners VI, LLC10% owner · 10% owner at Latigo Biotherapeutics, filing Form 4 there in the last year
Sanofi10% owner · 10% owner at Latigo Biotherapeutics, filing Form 4 there in the last year
Westlake BioPartners Fund I, L.P.10% owner · 10% owner at Latigo Biotherapeutics, filing Form 4 there in the last year
Beth C. SeidenbergDirector and 10% owner · Director and 10% owner at Latigo Biotherapeutics, filing Form 4 there in the last year
Foresite Capital Management V, LLC10% owner · 10% owner at Latigo Biotherapeutics, filing Form 4 there in the last year
Benjamin HohlChief Financial Officer · Also traded ELVN in the last 90 days
Helen Louise CollinsChief Medical Officer · Also traded ELVN in the last 90 days
J. Scott GarlandDirector · Also traded ELVN in the last 90 days